Disruption to supply of Metacam, Pexion and Semintra

25 Jul 2020

Barrett, L.

Vet Record Image

Over the next few months Boehringer Ingelheim is anticipating temporary interruptions in the supply of certain Metacam oral presentations, along with Pexion and Semintra. The disruption in supply of these products is likely to be significant for veterinary practices in the UK.

This is due to the impact of the Covid-19 pandemic. Due to the local conditions at one of our manufacturing sites, which is located in a region of the world badly affected by Covid-19, the implementation of additional safety measures at the site has become critical. These measures have resulted in a considerable reduction in the workforce and, consequently, the output at our plant has been temporarily reduced. As a result, we anticipate that it will take a few months before we resume normal supply levels.

We anticipate that it will take a few months before we resume normal supply levels

We sincerely apologise for this...